LSD, magic mushrooms, MDMA, ketamine, DMT… it’s a suspicious product line for a legitimate business — and psychedelics startups know it. With that in mind, it’s unsurprising that the sector are wary of the stereotypes around hallucinogens. “What the industry really needs is the most boring person in the room to be presenting the topic,” says Clara Burtenshaw…
Read More
About The Author
